50
Views
1
CrossRef citations to date
0
Altmetric
Corrigendum

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]

Page 231 | Published online: 19 Apr 2017